Article Details
Retrieved on: 2021-12-31 08:57:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HER2-targeting agents, such as the monoclonal antibodies trastuzumab and pertuzumab, improved outcomes in patients with breast cancer and ...
Article found on: www.pnas.org
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here